Targeting Key Signaling Pathways in Glioblastoma Stem Cells for the Development of Efficient Chemo- and Immunotherapy

Glioblastoma multiforme (GBM) is the most aggressive and most common malignant brain tumor with poor patient survival despite therapeutic intervention. On the cellular level, GBM comprises a rare population of glioblastoma stem cells (GSCs), driving therapeutic resistance, invasion, and recurrence....

Descripción completa

Detalles Bibliográficos
Autores principales: Helweg, Laureen P., Storm, Jonathan, Witte, Kaya E., Schulten, Wiebke, Wrachtrup, Lennart, Janotte, Till, Kitke, Angelika, Greiner, Johannes F. W., Knabbe, Cornelius, Kaltschmidt, Barbara, Simon, Matthias, Kaltschmidt, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659205/
https://www.ncbi.nlm.nih.gov/pubmed/36361720
http://dx.doi.org/10.3390/ijms232112919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659205/
https://www.ncbi.nlm.nih.gov/pubmed/36361720
http://dx.doi.org/10.3390/ijms232112919

Ejemplares similares